Search results
Results from the WOW.Com Content Network
A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people. Doctors speak about how this could improve screening rates and outcomes.
The Food and Drug Administration (FDA) has recently approved a blood test screening for colorectal cancer that has an over 83% success rate at detecting the presence of this form of cancer.
U.S. health regulators on Monday approved a first-of-its-kind blood test for colon cancer, offering a new way of screening for a leading cause of cancer deaths. Test manufacturer Guardant said the ...
The Oncotype DX Colon Cancer Assay is a genomic test for patients with newly diagnosed stage II colon cancer, launched in January 2010 by Genomic Health.The test is a validated diagnostic assay based on an individual patient's colon tumor expression of 12 genes, which quantifies the likelihood of recurrence in stage II colon cancer following surgery.
Some medical societies in the US recommend a screening colonoscopy every 10 years beginning at age 50 for adults without increased risk for colorectal cancer. [25] Research shows that the risk of cancer is low for 10 years if a high-quality colonoscopy does not detect cancer, so tests for this purpose are indicated every ten years. [25] [26]
For years, the gold standard in screening for colon cancer has been a colonoscopy.. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...
The procedure is performed either to look for colon polyps and/or colon cancer in somebody without symptoms, referred to as screening, or to further evaluate symptoms including rectal bleeding, dark tarry stools, change in bowel habits or stool consistency (diarrhea, pencil-thin stool), abdominal pain, and unexplained weight loss.
The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer.